1. Home
  2. GPRE vs IVVD Comparison

GPRE vs IVVD Comparison

Compare GPRE & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Green Plains Inc.

GPRE

Green Plains Inc.

HOLD

Current Price

$9.63

Market Cap

631.4M

Sector

Industrials

ML Signal

HOLD

Logo Invivyd Inc.

IVVD

Invivyd Inc.

HOLD

Current Price

$2.42

Market Cap

692.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GPRE
IVVD
Founded
2004
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
631.4M
692.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
GPRE
IVVD
Price
$9.63
$2.42
Analyst Decision
Hold
Strong Buy
Analyst Count
8
5
Target Price
$8.19
$8.75
AVG Volume (30 Days)
958.7K
4.7M
Earning Date
02-06-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,246,853,000.00
$50,039,000.00
Revenue This Year
N/A
$103.88
Revenue Next Year
N/A
$171.40
P/E Ratio
N/A
N/A
Revenue Growth
N/A
332.71
52 Week Low
$3.14
$0.35
52 Week High
$12.31
$3.07

Technical Indicators

Market Signals
Indicator
GPRE
IVVD
Relative Strength Index (RSI) 46.04 49.87
Support Level $9.50 $2.37
Resistance Level $10.78 $2.59
Average True Range (ATR) 0.45 0.20
MACD 0.01 -0.03
Stochastic Oscillator 15.94 21.71

Price Performance

Historical Comparison
GPRE
IVVD

About GPRE Green Plains Inc.

Green Plains Inc manufactures and sells ethanol and ethanol byproducts in two segments based on function. The ethanol production segment, which generates the majority of revenue, includes the production of ethanol, distillers grains, Ultra-High Protein and renewable corn oil. The agribusiness and energy services segment includes grain handling and storage, commodity marketing and merchant trading for company-produced and third-party ethanol, distillers grains, Ultra-High Protein, renewable corn oil, natural gas and other commodities.

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

Share on Social Networks: